Schedule 13G ownership disclosure
Zenas Biopharma Inc
Common Stock, par value $0.0001 · CUSIP: 98937L105
Event date: 2025-09-30
- Filing-level shares
- 2,000,000.00
- Percent of class
- 4.7%
- Novo Holdings A/S
Shares: 2,000,000.00 · Class: 4.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001388325-25-000027
- Form type
- SCHEDULE 13G/A
- Filer
- Novo Holdings A/S
- CIK
- CIK 1388325
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership